ATP-Responsive Liposomes for Selective Drug Cargo Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing liposomal delivery systems struggle with controlling the timing and location of cargo release due to minimal differences between diseased and healthy cells, and external stimuli methods risk harming non-target cells or regions.
Innovation Solution
Development of liposomes with lipid switch molecules that change shape upon binding to target phosphorylated molecules like ATP, disrupting the membrane and releasing therapeutic agents selectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If passive release methods relying on internal stimuli (pH, redox, enzyme expression) are used, then cargo release can be triggered by diseased cell characteristics, but the minimal differences between diseased and healthy cells limit targeted release effectiveness
Solution Approach 1:
The patent changes the stimulus parameter from relying on minimal passive differences (pH 6.5-6.7 vs 7.2-7.4) to detecting active phosphorylated molecules (ATP, cAMP, cGMP) that show significant concentration differences between diseased and healthy cells, enabling reliable targeted release
Solution Approach 2:
The patent replaces passive physical/chemical stimulus detection (pH, redox) with active biomolecular recognition (phosphorylated molecule binding to R2 groups), substituting a more specific biochemical detection mechanism
2Ease of operation
If active release methods using external stimuli (light, heat, ultrasound) are used, then cargo release timing and location can be controlled, but non-target cells or regions may be harmed by the extrinsic stimuli
Solution Approach 1:
The liposome system performs self-service by using its own membrane components (R2 groups) to detect and bind phosphorylated molecules, triggering automatic shape change and cargo release without requiring external stimuli that could harm non-target cells
Solution Approach 2:
The R2 groups act as intermediaries between the liposome membrane and phosphorylated molecules, enabling specific recognition and triggering of cargo release through molecular binding rather than harmful external physical stimuli
3Reliability
If lipid switch molecules are incorporated into liposome membrane, then selective cargo release can be achieved through shape change upon phosphorylated molecule binding, but the liposome membrane stability may be compromised
Solution Approach 1:
The liposome membrane is designed with dynamic properties, allowing it to maintain stability in its inactive state while being capable of undergoing controlled shape changes when phosphorylated molecules bind to R2 groups, enabling selective cargo release
Solution Approach 2:
The membrane transitions between stable and unstable states through parameter changes triggered by phosphorylated molecule binding, allowing controlled cargo release while maintaining overall membrane stability during circulation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The lipid switch liposomes enable targeted and controlled release of therapeutic agents to diseased cells, such as cancer cells, by altering their shape in response to specific intracellular signals, enhancing delivery specificity and reducing harm to healthy cells.
Implementation Method 1
the molecule functions as a lipid switch configured to change shape when a phosphorylated molecule becomes bound to the R2 groups, thereby disrupting the liposome membrane and releasing the therapeutic agent
Data Source
AI summary
Dimer and monomer molecules according to general formulas (I) or (II) are useful as lipid switch molecules when incorporated into a membrane of a liposome.wherein R1 is a hydrophobic tail having at least 6 carbons and wherein R2 is selected from the group consisting of —NH2,wherein, for the dimer, the linker is a saturated carbon chain having 2 to 6 carbons or is a para-xylene linker; and when R2 is charged anions are present to render the charge neutral. These molecules can bind ATP or similar small phosphorylated molecules between R2 groups, which changes the shape of the molecule or the molecules orientation within the membrane thereby acting as a “switch” to release a therapeutic agent from the liposome.